FGFR4 does not contribute to progression of chronic kidney disease

por Taylor, Ashlee, Yanucil, Christopher, Musgrove, John, Shi, Melody, Ide, Shintaro, Souma, Tomokazu, Faul, Christian, Wolf, Myles, Grabner, Alexander
Publicado 2019

Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling

por Czaya, Brian, Heitman, Kylie, Campos, Isaac, Yanucil, Christopher, Kentrup, Dominik, Westbrook, David, Gutierrez, Orlando, Babitt, Jodie L, Jung, Grace, Salusky, Isidro B, Hanudel, Mark, Faul, Christian
Publicado 2022

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible

por Grabner, Alexander, Schramm, Karla, Silswal, Neerupma, Hendrix, Matt, Yanucil, Christopher, Czaya, Brian, Singh, Saurav, Wolf, Myles, Hermann, Sven, Stypmann, Jörg, Di Marco, Giovana Seno, Brand, Marcus, Wacker, Michael J., Faul, Christian
Publicado 2017

FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes

por Yanucil, Christopher, Kentrup, Dominik, Li, Xueyi, Grabner, Alexander, Schramm, Karla, Martinez, Eliana C., Li, Jinliang, Campos, Isaac, Czaya, Brian, Heitman, Kylie, Westbrook, David, Wende, Adam R., Sloan, Alexis, Roche, Johanna M., Fornoni, Alessia, Kapiloff, Michael S., Faul, Christian
Publicado 2022